Показано 0 из 0
Дата |
---|
10.04.2024 |
09.04.2024 |
08.04.2024 |
05.04.2024 |
04.04.2024 |
03.04.2024 |
02.04.2024 |
28.03.2024 |
27.03.2024 |
26.03.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.188
|
0.188
|
0.188
|
0.188
|
|
|
|
|
|
|
0.188
|
0.188
|
0.188
|
0.188
|
|
|
564.00
|
2.00
|
0.191
|
0.208
|
0.165
|
0.165
|
0.177
|
0.177
|
|
|
|
|
0.171
|
0.191
|
0.188
|
0.188
|
0.188
|
0.188
|
|
|
|
|
0.191
|
0.208
|
0.169
|
0.169
|
0.171
|
0.171
|
|
|
|
|
0.175
|
0.196
|
0.115
|
0.115
|
0.115
|
0.115
|
|
|
|
|
0.117
|
0.135
|
0.102
|
0.102
|
0.102
|
0.102
|
|
|
|
|
0.29
|
0.32
|
0.28
|
0.28
|
0.288
|
0.288
|
|
|
|
|
0.282
|
0.31
|
0.276
|
0.276
|
0.28
|
0.28
|
|
|
|
|
0.278
|
0.306
|
0.286
|
0.286
|
0.286
|
0.286
|
|
|
|
|
Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent protected pharmaceuticals in Canada, Europe, and the United States. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs.